Women going through menopause while managing diabetes have told Diabetes UK that they often feel overlooked and under-supported and that this issue has received too little attention in both research and healthcare To address this, Diabetes UK convened a dedicated workshop through their Diabetes Research Steering Groups, bringing together women with lived experience, researchers [...]
The Medicines and Healthcare products Regulatory Agency (MHRA) has become the first regulator in the world to approve elinzanetant (Lynkuet) for the treatment of moderate to severe vasomotor symptoms (hot flushes) associated with the menopause. Further information is available on the gov.uk website.
We are deeply saddened to learn of the untimely death of Anthony Mander, Consultant Gynaecologist who, since retiring from the NHS, specialised in menopause health and lifestyle, working in both in Oxford and Oldham. Tony worked as a Consultant Obstetrician & Gynaecologist at The Royal Oldham Hospital for many years, where he developed a [...]
The Government announces that 29,000 extra bone scans will be delivered each year, helping with earlier diagnosis of illness such as osteoporosis For further information and to view the full press release click here
We are very pleased to announce the publication of a new BMS Tool for Clinicians – Use of incretin-based therapies in women using hormone replacement therapy (HRT). This new Tool for Clinicians is an important addition to the suite of BMS resources that are designed to support healthcare professionals in the management of women’s health. [...]
The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Drug Safety Update (DSU) informing healthcare professionals that fezolinetant treatment is associated with a risk of drug induced liver disease. Fezolinetant is used for the treatment of moderate to severe vasomotor symptoms, including hot flushes and night sweats, associated with the menopause. There have [...]
Supporting the O&G workforce to deliver the highest levels of care to women and girls is a key strategic priority for the Royal College of Obstetricians and Gynaecologists (RCOG). The RCOG is conducting a workforce census for all obstetricians and gynaecologists working in the UK, regardless of whether or not they currently hold any [...]
To coincide with International Women’s Day on 8 March 2025, we are delighted to share an article published on the ITN Business website: How the BMS Management of the Menopause Certificate is transforming patient care In June 2024, the BMS launched the BMS Management of the Menopause Certificate — a fully online qualification designed to give [...]
Further to the BMS News Alert issued on 20 February 2025, the MHRA has now provided the British Menopause Society with information about the availability of subcutaneous hormone implants: Unlicensed hormone replacement therapy (HRT) subcutaneous implants supply issue Following your recent enquiry, you will be aware of a supply issue regarding HRT subcutaneous implants [...]
Subcutaneous hormone implants are currently unavailable whilst the Medicines and Healthcare products Regulatory Agency (MHRA) undertakes a review. Until recently, these implants were available from a small number of specialist centres in the UK. The British Menopause Society (BMS) feels strongly that they remain an important treatment option for women who fail to respond [...]
